Superior vena cava obstruction

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

The superior vena cava returns blood from the head, neck, upper limbs and upper chest. Gradual narrowing allows azygos and chest-wall collaterals to enlarge, whereas rapid occlusion produces more severe pressure because compensatory channels have not developed. The obstruction may be external compression, direct tumour invasion, intraluminal thrombus or a combination around a venous device.

Symptoms reflect raised upper-body venous pressure. Ask about facial puffiness on waking, tight collars, arm or breast swelling, head pressure, visual change, dizziness, cough, dysphagia, hoarseness and positional breathlessness. Look for facial plethora or cyanosis, conjunctival oedema, distended non-pulsatile neck and chest veins and upper-limb asymmetry. A normal jugular venous pulsation pattern becomes difficult to interpret in severe obstruction.

Most presentations are uncomfortable rather than immediately fatal, so the first decision is severity. Sit the person upright, assess airway and oxygenation, look for stridor and laryngeal swelling and check cognition, headache, syncope and haemodynamic stability. Avoid reflex fluid loading into an obstructed upper-body circulation. Establish reliable venous access with senior or interventional advice; a lower-limb route may be preferable when upper access is compromised.

Contrast CT maps the obstruction and its cause. A venous-phase study can define thrombus, collateral flow and suitability for stenting while also identifying a lung mass or lymphadenopathy. Ultrasound assesses jugular, subclavian and axillary thrombus but cannot fully evaluate the intrathoracic cava. Venography is the procedural reference during stent or thrombus intervention rather than the routine first diagnostic test.

When the patient is stable, secure histology before cancer treatment: sputum, accessible node, pleural fluid, bronchoscopy or image-guided biopsy may provide tissue. Radiotherapy and corticosteroids can shrink lymphoma and reduce biopsy yield. In severe airway or cerebral compromise, immediate decompression takes priority; stenting generally does not prevent later biopsy, radiotherapy or systemic treatment.

Endovascular stenting can relieve venous pressure within hours to a few days and is favoured for severe symptoms, uncertain tumour response or recurrence after treatment. Interventional teams assess thrombus burden, bleeding, access and expected benefit. Anticoagulation after stenting varies with thrombus, device and local practice; there is no single regimen for every malignant stent, so haematology and interventional documentation must be explicit.

Disease-directed therapy follows histology. Lymphoma and small-cell lung cancer may respond rapidly to systemic treatment; radiotherapy can treat radiosensitive or locally compressive disease but is slower than a stent for immediate relief. For a patient near death who declines intervention, use upright care, airflow, oxygen for hypoxaemia, opioids for breathlessness and anxiety support while avoiding burdensome diagnostics that cannot change the plan.

Key points

Superior vena cava obstruction causes facial, neck and arm swelling, venous distension, plethora, breathlessness, cough and headache that often worsen when lying flat or bending forward.
Stridor, laryngeal oedema, severe hypoxia, syncope, confusion or reduced consciousness indicates airway, cerebral or haemodynamic compromise and needs immediate senior intervention.
Cancer is the commonest cause, especially lung cancer and lymphoma, but central venous catheters and thrombosis increasingly cause benign or mixed obstruction.
First-line assessment uses ABCDE, seated positioning, oxygen only for hypoxaemia, focused venous and neurological examination and review of line, cancer, anticoagulant and bleeding history.
Contrast-enhanced CT of the chest with venous-phase definition is the key anatomical investigation; it shows level, length, collateral pathways, tumour, nodes and thrombus.
If the patient is stable and cancer has not been diagnosed, obtain tissue before radiotherapy or empirical corticosteroid because histology determines definitive treatment.
Endovascular stenting usually gives the fastest symptom relief in severe malignant obstruction and can be performed before histology when immediate decompression is necessary.
Fresh catheter-associated or bland thrombus may need anticoagulation and selected thrombolysis or thrombectomy; tumour compression requires cancer-specific systemic therapy or radiotherapy.
Corticosteroids are not routine treatment for every SVCO; consider them for steroid-sensitive lymphoma, marked tumour oedema or airway compromise with acute-oncology advice.
Document whether the goal is rapid symptom relief, disease response, durable venous patency or comfort alone and match procedure burden and aftercare accordingly.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Intrathoracic malignancy

Lung cancer, lymphoma, mediastinal nodal metastases and other thoracic tumours compress or invade the thin-walled cava.

Catheter-related thrombosis

Central venous catheters, ports, dialysis lines and pacing leads disturb flow and endothelium, generating partial or complete thrombotic occlusion.

Mixed tumour and thrombus

Malignant narrowing slows blood, while a device or hypercoagulable state adds clot, so external and intraluminal mechanisms frequently coexist.

Uncommon benign narrowing

Fibrosing mediastinitis, previous radiotherapy, infection and postoperative scarring can produce chronic stenosis with extensive collateral veins.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Outflow resistance
Narrowing between the brachiocephalic confluence and right atrium raises venous pressure throughout the upper-body drainage territory.
2
Collateral recruitment
Blood diverts through azygos, internal mammary, vertebral and chest-wall channels; slower onset allows wider collaterals and less abrupt symptoms.
3
Interstitial fluid shift
High venous hydrostatic pressure drives fluid into facial, laryngeal, upper-limb and cerebral tissues, causing oedema and pressure symptoms.
4
Airway and cerebral effects
Laryngeal swelling narrows the airway, while impaired cranial venous drainage can raise intracranial pressure and reduce alertness.
5
Thrombotic propagation
Stasis, malignant hypercoagulability and foreign intravascular material allow thrombus to extend into jugular, subclavian or brachiocephalic veins.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Upper-body oedema

Morning facial puffiness, neck fullness and bilateral arm or breast swelling that worsens supine suggests impaired caval return.

Collateral venous pattern

Prominent non-pulsatile veins across the neck and upper chest with downward collateral flow strongly supports chronic central obstruction.

Pressure symptoms

Headache, visual blurring, dizziness, cough and a sense of head fullness often worsen on bending, coughing or lying down.

Respiratory involvement

Breathlessness, hoarseness, dysphagia or stridor may reflect venous oedema, tumour airway compression, pleural disease or several processes together.

Device-associated pattern

A port, dialysis catheter or pacing lead plus acute asymmetric arm and neck swelling raises thrombotic obstruction.

Critical SVCORed flag

Stridor, severe hypoxaemia, syncope, confusion, reduced consciousness or haemodynamic compromise requires immediate acute-oncology and airway or interventional support.

Red flags requiring action

Stridor, drooling, rapidly worsening hoarseness or inability to lie back suggests threatened upper airway.
Confusion, syncope, severe headache, vomiting, visual change or reduced consciousness suggests critical cerebral venous hypertension.
Severe hypoxaemia may reflect central airway obstruction, pleural disease, embolism or infection in addition to SVCO.
Abrupt unilateral arm and neck swelling around a central device raises fresh thrombosis that may be amenable to early intervention.
Hypotension or collapse is unusual in uncomplicated SVCO and should trigger a search for haemorrhage, sepsis, tamponade or embolism.
Empirical radiotherapy or corticosteroid before tissue can compromise lymphoma diagnosis when the patient is otherwise stable.
Upper-limb cannulation and high-volume infusion can worsen congestion or fail to reach the central circulation reliably.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Immediate severity and airway assessmentFirst step
Why
Record posture tolerance, oxygenation, stridor, voice, facial and limb swelling, venous pattern, cognition, syncope and haemodynamic state.
Interpretation and limitations
Airway, cerebral or circulatory compromise accelerates decompression and senior support before a conventional diagnostic sequence.
02
Contrast-enhanced CT chest
Why
Define obstruction level and length, tumour, nodes, airway, pleura, thrombus and collateral circulation using an appropriate venous phase.
Interpretation and limitations
This is the first-line anatomical study and guides biopsy, stent, radiotherapy and systemic-treatment decisions.
03
Duplex ultrasound of accessible veins
Why
Assess jugular, axillary and subclavian thrombosis and catheter-associated peripheral extension without contrast exposure.
Interpretation and limitations
A positive study supports anticoagulation planning, but a negative result does not exclude intrathoracic caval obstruction.
04
Catheter venography during intervention
Why
Display real-time lumen, pressure and collateral anatomy during stenting, thrombolysis or thrombectomy.
Interpretation and limitations
This is the procedural reference standard but is invasive and is not required before every diagnostic CT.
05
Least invasive tissue diagnosis
Why
Use accessible node, pleural fluid, bronchoscopy or image-guided biopsy after imaging when malignancy is not already confirmed.
Interpretation and limitations
Histology is the gold standard for tumour-specific therapy; preserve yield unless emergency decompression must take precedence.
06
Treatment baseline tests
Why
Check full blood count, renal and liver function, coagulation, group and save and ECG when contrast, anticoagulation, intervention or treatment is likely.
Interpretation and limitations
Results inform bleeding, contrast, anaesthetic and systemic-treatment safety but should not delay lifesaving management of critical obstruction.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Right heart failure

Raised pulsatile jugular pressure, peripheral oedema, hepatomegaly and cardiac findings occur without the same upper-body collateral pattern.

Anaphylaxis or angioedema

Abrupt lip or tongue swelling, urticaria, wheeze and shock indicate an allergic emergency rather than progressive venous congestion.

Upper-limb deep-vein thrombosis

Unilateral arm swelling around a line may be peripheral thrombosis alone or extension toward the cava and requires venous imaging.

Lymphatic obstruction

Postoperative or malignant lymphoedema is often asymmetric, chronic and less associated with facial plethora or dilated chest veins.

Airway tumour without SVCO

Stridor, cough and dyspnoea from central airway narrowing can coexist with or mimic venous obstruction and changes emergency priorities.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01Critical obstructionStabilise and decompress without delayFirst stepSVCO causes stridor, severe respiratory compromise, cerebral dysfunction or haemodynamic instability.

1Sit upright, use ABCDE care, give oxygen for hypoxaemia and involve airway, respiratory, acute-oncology and interventional specialists immediately.
2Obtain urgent contrast CT when safe and plan venous access and rescue around both caval and possible central-airway obstruction.
3Use endovascular stenting or another fastest effective intervention without waiting for routine histology, then secure tissue and disease treatment after stabilisation.

02Stable malignant SVCOSecure diagnosis then match tumour treatmentSymptoms are significant but there is no airway, cerebral or circulatory emergency and malignancy is suspected.

1Perform contrast CT, stage immediate anatomy and obtain the least invasive adequate tissue before empirical radiotherapy or corticosteroid when feasible.
2Discuss stent for rapid relief versus systemic therapy or radiotherapy for tumour response, considering histology, symptom tempo, prior treatment, prognosis and preference.
3EscalationProvide upright symptom care and a named escalation route while treatment begins, with explicit review for worsening voice, breathing or cognition.

03Thrombotic SVCOTreat clot and correct device factorsImaging shows bland or catheter-associated thrombus with or without malignant narrowing.

1Assess onset, clot extent, catheter need, bleeding, platelet count, renal function and planned biopsy or procedure with haematology and interventional teams.
2Begin an appropriate anticoagulant when safe and consider catheter-directed thrombolysis or thrombectomy for recent severe thrombosis in selected patients.
3Decide whether to retain, reposition or remove the device and document anticoagulation duration, stent plan and recurrence monitoring.

04Comfort-focused careRelieve distress when procedures do not fitThe person declines intervention or is too close to death for its likely benefit to outweigh burden.

1EscalationExplain the mechanism and expected course honestly, confirm escalation and place-of-care preferences and avoid tests that cannot change treatment.
2Use upright positioning, cool airflow, oxygen for hypoxaemia, opioid titration for breathlessness and proportionate anxiety treatment while preserving alertness where desired.
3Prepare carers and community teams for worsening swelling, airway symptoms or consciousness and provide rapid access to anticipatory medicines and support.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

Prevents propagation and recurrence when bland or catheter-associated thrombus contributes to caval obstruction.

Anticoagulation for confirmed thrombotic obstruction

Choose and dose low-molecular-weight heparin or another anticoagulant according to active cancer, renal and hepatic function, platelet count, bleeding risk, interactions and planned biopsy or stenting under the local cancer-associated thrombosis pathway.

Anticoagulation does not rapidly remove fixed tumour compression; coordinate with intervention and avoid or modify during active bleeding, profound thrombocytopenia or incompatible goals.

May reduce inflammatory tumour oedema while definitive biopsy, systemic treatment, radiotherapy or stenting is organised.

Selective dexamethasone for oedematous tumour

When acute oncology recommends treatment for steroid-sensitive lymphoma, marked tumour oedema or airway compromise, use the locally specified dexamethasone regimen and set an early response and taper review.

It is not routine therapy for all SVCO and may reduce lymphoma biopsy yield; monitor glucose, infection, mental state and gastrointestinal risk.

Reduces the central perception of breathlessness while anatomical treatment takes effect or when intervention is not wanted.

Opioid relief for associated breathlessness

For a patient already taking opioids, use an agreed proportion of the current immediate-release dose; for an opioid-naive frail patient, start a low immediate-release dose under palliative guidance and titrate to comfort and alertness.

Adjust for renal impairment and monitor sedation, respiratory rate, delirium and constipation; oxygen treats hypoxaemia rather than breathlessness alone.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Laryngeal obstruction

Progressive pharyngeal or laryngeal oedema causes hoarseness, stridor, work of breathing and potentially fatal airway loss.

Cerebral venous hypertension

Headache, vomiting, visual disturbance, confusion, syncope, seizure and coma can develop when intracranial venous drainage becomes critically impaired.

Venous thrombosis and embolism

Catheter and caval thrombus can propagate, compromise access, occlude a stent or contribute to pulmonary embolic disease.

Procedure-related injury

Stenting may cause bleeding, migration, vessel rupture, arrhythmia, contrast kidney injury or re-occlusion and requires planned follow-up.

Persistent functional distress

Facial change, inability to lie flat, breathlessness and arm swelling impair sleep, eating, self-image and tolerance of further cancer treatment.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Repeat voice, stridor, respiratory rate, oxygenation, posture tolerance, cognition and headache while urgent treatment is arranged.
Measure facial, neck and arm swelling clinically and ask about sleep, swallowing and the ability to lie flat rather than relying only on imaging.
After stenting observe access site, bleeding, chest pain, arrhythmia and early symptom relief and follow the interventional patency plan.
During anticoagulation monitor bleeding, platelet count, renal function, interactions and planned procedures at clinically appropriate intervals.
During corticosteroid treatment review the exact indication, glucose, infection, mood and biopsy status and set a taper date.
During tumour treatment assess response and toxicity and maintain an escalation route because venous or airway symptoms can progress before shrinkage.
Revisit goals if symptom benefit is brief or disease progresses and ensure comfort treatment continues during any change of intent.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Tempo predicts tolerance

Slow obstruction permits collateral enlargement, so dramatic chest veins can coexist with greater stability than a subtle acute occlusion.

SVCO is not always cancer

An indwelling line or pacing lead makes bland thrombosis important because anticoagulation and device decisions may be central.

Stenting preserves later options

Rapid mechanical relief can be delivered before histology without usually preventing subsequent biopsy, radiotherapy or systemic treatment.

Steroids can erase evidence

Lymphoma can shrink quickly after corticosteroid exposure, so stable patients should have diagnostic tissue protected whenever feasible.

Hypoxia needs a second diagnosis

Marked oxygen impairment is not explained reliably by venous pressure alone and should prompt airway, pleural, embolic and infective assessment.

Aftercare is not uniform

Antithrombotic treatment after malignant caval stenting depends on clot, bleeding and device factors and needs a documented specialist plan.

11Common pitfallsFrequent interpretation and management errors.

01
Assuming every facial swelling episode in cancer is SVCO without considering anaphylaxis or fluid overload.
02
Laying a severely symptomatic patient flat for convenience before airway and posture tolerance are assessed.
03
Giving oxygen for breathlessness without checking whether hypoxaemia is present or another thoracic emergency coexists.
04
Using ultrasound alone to exclude intrathoracic caval obstruction.
05
Starting empirical radiotherapy before tissue diagnosis in a stable undiagnosed patient.
06
Prescribing dexamethasone routinely without a steroid-responsive indication or biopsy plan.
07
Ignoring catheter-associated thrombosis because a mediastinal tumour is also visible.
08
Infusing large volumes through obstructed upper-limb venous access.
09
Assuming every stent requires the same anticoagulation regimen.
10
Focusing on anatomy while neglecting breathlessness, fear, sleep and communication with carers.